Pediatric Nephrology

, Volume 22, Issue 4, pp 509–513 | Cite as

Mutational analysis of NPHS2 and WT1 in frequently relapsing and steroid-dependent nephrotic syndrome

  • Rasheed Gbadegesin
  • Bernward Hinkes
  • Christopher Vlangos
  • Bettina Mucha
  • Jinhong Liu
  • Jeff Hopcian
  • Friedhelm HildebrandtEmail author
Original Article


Idiopathic nephrotic syndrome is a common pediatric kidney disease, 80% of all cases are steroid sensitive (SSNS). A significant proportion of children with SSNS will have a frequently relapsing or steroid-dependent course (FRNS/SDNS) that is associated with significant treatment-related morbidity. Mutations in NPHS2 account for more than 28% of all cases of steroid-resistant nephrotic syndrome (SRNS) and dominant mutations in WT1 for 5%; while mutations are absent from children with uncomplicated SSNS. Since FRNS/SDNS is phenotypically positioned within a spectrum between SSNS and SRNS, we hypothesized that heterozygous mutations of NPHS2 may be causing FRNS/SDNS. Mutational analysis of NPHS2 and WT1 was carried out in a single-center cohort of 20 children with FRNS/SDNS, ten children with uncomplicated SSNS (control), and 22 children with SRNS (control). Renal biopsy findings were available in 15/20 children with FRNS/SDNS and revealed IgM nephropathy, MCNS, and FSGS in six, five, and four children, respectively. Children with FRNS/SDNS were significantly younger at first presentation than those with SSNS and SRNS (median age: 3.0 years in FRNS/SDNS patients, 7.0 years in SSNS patients, and 5.0 in SRNS patients; p < 0.001). No NPHS2 or WT1 mutations were found in patients with FRNS/SDNS and uncomplicated SSNS. The hypothesis that FRNS/SDNS may be associated with heterozygous mutations in NPHS2 or WT1 was not confirmed.


Frequently relapsing/steroid-dependent Mutational analysis Nephrotic syndrome Podocin WT1 



We would like to thank the patients and their parents for their participation in this study. We would also like to thank Drs. D. Kershaw, P. Brophy, J. Lin, W. Smoyer, and S. Thomas for allowing us to study their patients. We also thank Dr. B. Hoskins for proof reading the manuscript. F.H. is supported by grants from the NIH (P50-DK039255), the Smokler Foundation and the Thrasher Research Foundation.


  1. 1.
    Eddy AA, Symons JM (2003) Nephrotic syndrome in childhood. Lancet 362(9384):629–639PubMedCrossRefGoogle Scholar
  2. 2.
    Karle SM, Uetz B, Ronner V, Glaeser L, Hildebrandt F, Fuchshuber A (2002) Novel mutations in NPHS2 detected in both familial and sporadic steroid-resistant nephrotic syndrome. J Am Soc Nephrol 13(2):388–393PubMedGoogle Scholar
  3. 3.
    Ruf RG, Lichtenberger A, Karle SM, Haas JP, Anacleto FE, Schultheiss M, Zalewski I, Imm A, Ruf EM, Mucha B, Bagga A, Neuhaus T, Fuchshuber A, Bakkaloglu A, Hildebrandt F; Arbeitsgemeinschaft für Pädiatrische Nephrologie Study Group (2004) Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J Am Soc Nephrol 15(3):722–732PubMedCrossRefGoogle Scholar
  4. 4.
    Ruf RG, Schultheiss M, Lichtenberger A, Karle SM, Zalewski I, Mucha B, Everding AS, Neuhaus T, Patzer L, Plank C, Haas JP, Ozaltin F, Imm A, Fuchshuber A, Bakkaloglu A, Hildebrandt F; APN Study Group (2004) Prevalence of WT1 mutations in a large cohort of patients with steroid-resistant and steroid-sensitive nephrotic syndrome. Kidney Int 66(2):564–570PubMedCrossRefGoogle Scholar
  5. 5.
    Weber S, Gribouval O, Esquivel EL, Moriniere V, Tete MJ, Legendre C, Niaudet P, Antignac C (2004) NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence. Kidney Int 66(2):571–579PubMedCrossRefGoogle Scholar
  6. 6.
    Mucha B, Ozaltin F, Hinkes BG, Hasselbacher K, Ruf RG, Schultheiss M, Hangan D, Hoskins BE, Everding AS, Bogdanovic R, Seeman T, Hoppe B, Hildebrandt F; Members of the APN Study Group (2006) Mutations in the Wilms’ tumor 1 gene cause isolated steroid resistant nephrotic syndrome and occur in exons 8 and 9. Pediatr Res 59(2):325–331PubMedCrossRefGoogle Scholar
  7. 7.
    Lahdenkari AT, Suvanto M, Kajantie E, Koskimies O, Kestila M, Jalanko H (2005) Clinical features and outcome of childhood minimal change nephrotic syndrome: is genetics involved? Pediatr Nephrol 20(8):1073–1080PubMedCrossRefGoogle Scholar
  8. 8.
    Caridi G, Bertelli R, Di Duca M, Dagnino M, Emma F, Onetti Muda A, Scolari F, Miglietti N, Mazzucco G, Murer L, Carrea A, Massella L, Rizzoni G, Perfumo F, Ghiggeri GM (2003) Broadening the spectrum of diseases related to podocin mutations. J Am Soc Nephrol 14(5):1278–1286PubMedCrossRefGoogle Scholar
  9. 9.
    Hodson EM, Knight JF, Willis NS, Craig JC (2005) Corticosteroid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev (1):CD001533Google Scholar
  10. 10.
    Ehrich JH, Brodehl J (1993) Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft für Pädiatrische Nephrologie. Eur J Pediatr 152(4):357–361PubMedCrossRefGoogle Scholar
  11. 11.
    Schulman SL, Kaiser BA, Polinsky MS, Srinivasan R, Baluarte HJ (1988) Predicting the response to cytotoxic therapy for childhood nephrotic syndrome :superiority of response to corticosteroid therapy over histopathologic patterns. J Pediatr 113(6):996–1001PubMedCrossRefGoogle Scholar
  12. 12.
    Maniatis TF, Sambrook J (1987) Molecular cloning: A laboratory manual, 2nd edn. Cold Spring Arbor Laboratory, PlainviewGoogle Scholar
  13. 13.
    Otto E, Hoefele J, Ruf R, Mueller AM, Hiller KS, Wolf MT, Schuermann MJ, Becker A, Birkenhager R, Sudbrak R, Hennies HC, Nurnberg P, Hildebrandt F (2002) A gene mutated in nephronophthisis and retinitis pigmentosa encodes a novel protein, nephroretinin, conserved in evolution. Am J Hum Genet 71(5):1161–1167PubMedCrossRefGoogle Scholar
  14. 14.
    Franceschini N, North KE, Kopp JB, McKenzie L, Winkler C (2006) NPHS2 gene, nephrotic syndrome and focal segmental glomerulosclerosis: a HuGE review. Genet Med 8(2):63–75PubMedCrossRefGoogle Scholar
  15. 15.
    Boute N, Gribouval O, Roselli S, Benessy F, Lee H, Fuchshuber A, Dahan K, Gubler MC, Niaudet P, Antignac C (2000) NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 24(4):349–354PubMedCrossRefGoogle Scholar
  16. 16.
    Lenkkeri U, Mannikko M, McCready P, Lamerdin J, Gribouval O, Niaudet PM, Antignac C K, Kashtan CE, Holmberg C, Olsen A, Kestila M, Tryggvason K (1999) Structure of the gene for congenital nephrotic syndrome of the finnish type (NPHS1) and characterization of mutations. Am J Hum Genet 64(1):51–61PubMedCrossRefGoogle Scholar
  17. 17.
    Horinouchi I, Nakazato H, Kawano T, Iyama K, Furuse A, Arizono K, Machida J, Sakamoto T, Endo F, Hattori S (2003) In situ evaluation of podocin in normal and glomerular diseases. Kidney Int 64(6):2092–2099PubMedCrossRefGoogle Scholar
  18. 18.
    Patrakka J, Lahdenkari AT, Koskimies O, Holmberg C, Wartiovaara J, Jalanko H (2002) The number of podocyte slit diaphragms is decreased in minimal change nephrotic syndrome. Pediatr Res 52(3):349–355PubMedCrossRefGoogle Scholar

Copyright information

© IPNA 2007

Authors and Affiliations

  • Rasheed Gbadegesin
    • 1
  • Bernward Hinkes
    • 1
  • Christopher Vlangos
    • 1
  • Bettina Mucha
    • 1
  • Jinhong Liu
    • 1
  • Jeff Hopcian
    • 1
  • Friedhelm Hildebrandt
    • 1
    • 2
    • 3
    Email author
  1. 1.Department of Pediatrics Division of NephrologyAnn ArborUSA
  2. 2.Human GeneticsUniversity of MichiganAnn ArborUSA
  3. 3.University of Michigan Health SystemAnn ArborUSA

Personalised recommendations